|
|
|
|
LEADER |
01040naa a2200277 i 4500 |
001 |
NSK01001005711 |
003 |
HR-ZaNSK |
005 |
20180831080705.0 |
007 |
ta |
008 |
180831s2017 ci | |1|| ||eng |
035 |
|
|
|a (HR-ZaNSK)001005711
|
040 |
|
|
|a HR-ZaNSK
|b hrv
|c HR-ZaNSK
|e ppiak
|
042 |
|
|
|a croatica
|
044 |
|
|
|a ci
|c hr
|
080 |
1 |
|
|a 615
|2 2011
|
100 |
1 |
|
|a Varney, Amie
|4 aut
|
245 |
1 |
0 |
|a What are the risks associated with the use of NSAIDs as an adjunct to SSRIs for treatment of depression? :
|b an evaluation of current evidence /
|c Amie Varney, Kate Womersley, Mark Agius.
|
300 |
|
|
|b Ilustr.
|
500 |
|
|
|a 6th Cambridge International Conference on Mental Health, Cambridge, 22-22nd September 2017
|
504 |
|
|
|a Bibliografija: 49 jed.
|
653 |
|
0 |
|a Depresija
|a Antidepresivi
|a Protuupalni lijekovi
|a Nuspojave
|
700 |
1 |
|
|a Womersley, Kate
|4 aut
|
700 |
1 |
|
|a Agius, Mark
|4 aut
|
773 |
0 |
|
|t Psychiatria Danubina. Supplement
|x 1332-1366
|g 29 (2017), 3 ; str. 375-382
|w nsk.(HR-ZaNSK)000009867
|
981 |
|
|
|b B01/17
|
998 |
|
|
|b mamo1808
|